Peptide record

TPDB12265

Antibacterial Antiviral Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12265
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia dbAMP 3.0 DRAVP 2.0
standard
No
A 9-aa standard-residue multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from AntiBP3, Peptipedia, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
ATCYCRTGR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C40H67N15O13S2
NDEQHILKMFPSWV
RCT
1030.18
9.09
2
0
2
+2
3.31
-0.589
11.11
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
1615
1.57
5
Residue Composition
number
1
A
2
R
0
N
0
D
2
C
0
E
0
Q
1
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
2
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 1 R: 2 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 2 W: 0 Y: 1 V: 0
Chemical Descriptors
9 reviewed residue count
C40H67N15O13S2 sequence-only estimate (linear, free termini)
1030.18 sequence-only estimate (linear, free termini)
9.09 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
3.31 sequence-only estimate (linear, free termini)
-0.589 sequence-only estimate (linear, free termini)
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
25 µM

Target

A. baumannii 4-MRGN

Source & Reference

NA

Other

rhamnosus, L. salivarius, and S. solivarius salivarius. In addition, it is active against A. baumannii 4-MRGN (MIC 25 uM), K.pneumoniae 3-MRGN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747
Evidence 2 Activity

Activity

MIC
Antibacterial
50 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

NA

Other

on, it is active against A. baumannii 4-MRGN (MIC 25 uM), K.pneumoniae 3-MRGN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747 (MIC 12.5 uM), and S. aureus USA300 (MIC 50 uM). Updated 7/2021 3/202
Evidence 3 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

E. faecium 475747

Source & Reference

NA

Other

4-MRGN (MIC 25 uM), K.pneumoniae 3-MRGN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747 (MIC 12.5 uM), and S. aureus USA300 (MIC 50 uM). Updated 7/2021 3/2023
Evidence 4 Activity

Activity

MIC
Antibacterial
50 µM

Target

Staphylococcus aureus USA300

Source & Reference

NA

Other

GN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747 (MIC 12.5 uM), and S. aureus USA300 (MIC 50 uM). Updated 7/2021 3/2023
Evidence 5 Activity

Activity

MIC
Antiviral
25 µM

Target

A. baumannii 4-MRGN

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
dbAMP 3.0 classified under the Anti-viral function class.
rhamnosus, L. salivarius, and S. solivarius salivarius. In addition, it is active against A. baumannii 4-MRGN (MIC 25 uM), K.pneumoniae 3-MRGN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747
Evidence 6 Activity

Activity

MIC
Antiviral
50 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

on, it is active against A. baumannii 4-MRGN (MIC 25 uM), K.pneumoniae 3-MRGN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747 (MIC 12.5 uM), and S. aureus USA300 (MIC 50 uM). Updated 7/2021 3/202
Evidence 7 Activity

Activity

MIC
Antiviral
12.5 µM

Target

E. faecium 475747

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

4-MRGN (MIC 25 uM), K.pneumoniae 3-MRGN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747 (MIC 12.5 uM), and S. aureus USA300 (MIC 50 uM). Updated 7/2021 3/2023
Evidence 8 Activity

Activity

MIC
Antiviral
50 µM

Target

Staphylococcus aureus USA300

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

GN (inactive), P. aeruginosa ATCC 27853 (MIC 50 uM), E. faecium 475747 (MIC 12.5 uM), and S. aureus USA300 (MIC 50 uM). Updated 7/2021 3/2023
Evidence 9 Activity

Activity

50% Cytotoxicity
Toxicity
>150 µM
Cytotoxic
50% Cytotoxicity | >150 | µM | target cell: Human retinal epithelial cells ARPE-19

Target

Human retinal epithelial cells ARPE-19

Source & Reference

NA
DBAASP
The Human ?-Defensin-Derived Peptide HD5(1-9) Inhibits Cellular Attachment and Entry of Human Cytomegalovirus | Antiviral Res | 2020